Scientific publications 2016

  1. 21. Majdoul, S., A. K. Seye, et al. (2016). “Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells.” J Biol Chem 291(5): 2161-2169.
  2. 22. Mansour, R., et al. (2016). “Expression of myotubularins in blood platelets: Characterization and potential diagnostic of X-linked myotubular myopathy.” Biochem Biophys Res Commun 476(3): 167-173.
  3. 23. Martinet, J., et al. (2016). “Induction of Hematopoietic Microchimerism by Gene-Modified BMT Elicits Antigen-Specific B and T Cell Unresponsiveness toward Gene Therapy Products.” Front Immunol 7: 360.
  4. 24. Masat, E., et al. (2016). “Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.” Sci Rep 6: 36182.
  5. 25. Merten, O. W. (2016). AAV vector production: state of the art developments and remaining challenges. Cell & Gene Therapy Insights: 521-551.
  6. 26. Merten, O. W. and B. Gaillet (2016). “Viral vectors for gene therapy and gene modification approaches.” Biochem Engin J 108: 98-115.